The highly anticipated novel Retatrutide 20mg pen is gradually becoming available in the UK. Currently , access is limited and primarily via specialist healthcare providers participating in clinical studies . While a full, general commercial rollout date remains tentative, sources suggest that patients will be able to access the treatment via speci